Shin DH - Search Results

1

4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8⁺ T cell.

Cho E, Singh R, Han C, Kim SH, Kim KH, Park BM, Shin DH, Han S, Kim YH, Kwon BS, Nam KT, Choi BK. Cho E, et al. Among authors: shin dh. Cell Mol Immunol. 2023 Sep;20(9):1077-1080. doi: 10.1038/s41423-023-01056-3. Epub 2023 Jun 26. Cell Mol Immunol. 2023. PMID: 37365325 Free PMC article. No abstract available.

2

Midkine Is a Potential Therapeutic Target of Tumorigenesis, Angiogenesis, and Metastasis in Non-Small Cell Lung Cancer.

Shin DH, Jo JY, Kim SH, Choi M, Han C, Choi BK, Kim SS. Shin DH, et al. Cancers (Basel). 2020 Aug 24;12(9):2402. doi: 10.3390/cancers12092402. Cancers (Basel). 2020. PMID: 32847073 Free PMC article.

3

Chronic activation of 4-1BB signaling induces granuloma development in tumor-draining lymph nodes that is detrimental to subsequent CD8⁺ T cell responses.

Kim SH, Singh R, Han C, Cho E, Kim YI, Lee DG, Kim YH, Kim SS, Shin DH, You HJ, Lee HW, Kwon BS, Choi BK. Kim SH, et al. Among authors: shin dh. Cell Mol Immunol. 2021 Aug;18(8):1956-1968. doi: 10.1038/s41423-020-00533-3. Epub 2020 Aug 31. Cell Mol Immunol. 2021. PMID: 32868911 Free PMC article.

4

Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1.

Shin DH, Kim SH, Choi M, Bae YK, Han C, Choi BK, Kim SS, Han JY. Shin DH, et al. Oncogene. 2022 Jan;41(2):280-292. doi: 10.1038/s41388-021-02097-6. Epub 2021 Nov 6. Oncogene. 2022. PMID: 34743207

5

Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing Rag1 Knock-Out Mice.

Kim SH, Go EM, Shin DH, Choi BK, Han C. Kim SH, et al. Among authors: shin dh. Cells. 2022 Dec 2;11(23):3894. doi: 10.3390/cells11233894. Cells. 2022. PMID: 36497152 Free PMC article.

6

Farnesyl diphosphate synthase is important for the maintenance of glioblastoma stemness.

Kim HY, Kim DK, Bae SH, Gwak H, Jeon JH, Kim JK, Lee BI, You HJ, Shin DH, Kim YH, Kim SY, Han SS, Shim JK, Lee JH, Kang SG, Jang H. Kim HY, et al. Among authors: shin dh. Exp Mol Med. 2018 Oct 17;50(10):1-12. doi: 10.1038/s12276-018-0166-2. Exp Mol Med. 2018. PMID: 30333528 Free PMC article.

7

Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer.

Shin DH, Jo JY, Choi M, Kim KH, Bae YK, Kim SS. Shin DH, et al. Exp Mol Med. 2023 Oct;55(10):2220-2237. doi: 10.1038/s12276-023-01091-0. Epub 2023 Oct 2. Exp Mol Med. 2023. PMID: 37779142 Free PMC article.

8

Migration and invasion of drug-resistant lung adenocarcinoma cells are dependent on mitochondrial activity.

Jeon JH, Kim DK, Shin Y, Kim HY, Song B, Lee EY, Kim JK, You HJ, Cheong H, Shin DH, Kim ST, Cheong JH, Kim SY, Jang H. Jeon JH, et al. Among authors: shin dh, shin y. Exp Mol Med. 2016 Dec 9;48(12):e277. doi: 10.1038/emm.2016.129. Exp Mol Med. 2016. PMID: 27932791 Free PMC article.

9

Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism.

Kim YS, Lee YM, Oh TI, Shin DH, Kim GH, Kan SY, Kang H, Kim JH, Kim BM, Yim WJ, Lim JH. Kim YS, et al. Among authors: shin dh. Int J Mol Sci. 2018 Oct 12;19(10):3127. doi: 10.3390/ijms19103127. Int J Mol Sci. 2018. PMID: 30321984 Free PMC article.

10

Differential proteome expression analysis of androgen-dependent and -independent pathways in LNCaP prostate cancer cells.

Cha S, Shin DH, Seok JR, Myung JK. Cha S, et al. Among authors: shin dh. Exp Cell Res. 2017 Oct 1;359(1):215-225. doi: 10.1016/j.yexcr.2017.07.026. Epub 2017 Jul 20. Exp Cell Res. 2017. PMID: 28736082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,049 results

Search Page

Filters